Get the Stockscreener App
13.92
0.80%
0.11
Lensar Inc stock is traded at $13.92, with a volume of 99,732.
It is up +0.80% in the last 24 hours and up +2.13% over the past month.
LENSAR Inc is a commercial-stage medical device company focused on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts. The company Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, simplified procedure planning, efficient design, and precision. Its product portfolio consists of the LENSAR Laser System with Streamline IV and IntelliAxis and its associated consumable components. Geographically, the company generates the majority of its revenue from the United States, followed by Europe and Asia.
See More
Previous Close:
$13.81
Open:
$13.82
24h Volume:
99,732
Relative Volume:
0.58
Market Cap:
$164.62M
Revenue:
$42.16M
Net Income/Loss:
$-14.38M
P/E Ratio:
-7.7765
EPS:
-1.79
Net Cash Flow:
$-9.90M
1W Performance:
-0.29%
1M Performance:
+2.13%
6M Performance:
+88.62%
1Y Performance:
+264.40%
1-Day Range:
$13.80
$13.94
1-Week Range:
$13.68
$14.00
52-Week Range:
$3.47
$17.31
Lensar Inc Stock (LNSR) Company Profile
Name
Lensar Inc
Sector
Industry
Phone
888-536-7271
Address
2800 DISCOVERY DRIVE, ORLANDO
Compare LNSR with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
LNSR
Lensar Inc
|
13.92 | 164.62M | 42.16M | -14.38M | -9.90M | -1.79 |
|
ABT
Abbott Laboratories
|
133.24 | 231.09B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
102.86 | 155.24B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
380.92 | 144.54B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
83.48 | 108.82B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
73.68 | 44.31B | 5.54B | 4.18B | 623.10M | 7.00 |
Lensar Inc Stock (LNSR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-24-21 | Initiated | SVB Leerink | Outperform |
Lensar Inc Stock (LNSR) Latest News
LENSAR revenue up 34% to USD 14.2 million in Q1 2025 - Medical Buyer
LENSAR Reports Strong Q1 2025 Growth Amid Merger Plans - TipRanks
LENSAR Inc reports results for the quarter ended March 31Earnings Summary - TradingView
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of - GlobeNewswire
LENSAR, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2025 - marketscreener.com
LENSAR earnings missed by $2.17, revenue fell short of estimates - Investing.com
LNSR Achieves Strong Q1 Revenue Growth in 2025 | LNSR Stock News - GuruFocus
LENSAR Inc Reports Q1 2025 Earnings: Revenue Surpasses Estimates at $14.2M, EPS Falls Short at ($2.32) - GuruFocus
LENSAR Reports First Quarter 2025 Results and Provides Business Update - TradingView
LENSAR Reports First Quarter 2025 Results and Provides Business Update | LNSR Stock News - GuruFocus
LENSAR, Inc. Reports 34% Revenue Growth and 14 ALLY Systems Placed in Q1 2025 - Nasdaq
(LNSR) Technical Data - news.stocktradersdaily.com
LivaNova Reports First-Quarter 2025 Results; Updates 2025 Guidance | LIVN Stock News - GuruFocus
LivaNova Reports First-Quarter 2025 Results; Updates 2025 Guidance - Stock Titan
LENSAR Inc expected to post a loss of 15 cents a shareEarnings Preview - TradingView
Geode Capital Management LLC Buys 5,627 Shares of LENSAR, Inc. (NASDAQ:LNSR) - Defense World
LENSAR (LNSR) Projected to Post Earnings on Thursday - Defense World
LENSAR, Inc. (NASDAQ:LNSR) Short Interest Up 92.9% in April - Defense World
Halper Sadeh LLP, AZEK Company Inc., LENSAR, Inc., Dun & Bradstreet Holdings, Inc. - Olean Times Herald
LENSAR: It Is All About The Contingent Value Right Now (NASDAQ:LNSR) - Seeking Alpha
LENSAR (NASDAQ:LNSR) Stock Price Up 0.1% – Still a Buy? - Defense World
How to Take Advantage of moves in (LNSR) - news.stocktradersdaily.com
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates LNSR, TURN, DNB, GB on Behalf of Shareholders - GlobeNewswire Inc.
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: LENSAR, Inc. (NasdaqLNSR), 180 Degree Capital Corp. (Nasdaq – TURN), Dun & Bradstreet Holdings, Inc. (NYSEDNB), Global Blue Group Holding AG (N - TradingView
Is LENSAR (LNSR) a Deeply Undervalued Stock? - Insider Monkey
Trading (LNSR) With Integrated Risk Controls - news.stocktradersdaily.com
Taxation With Representation: Norton Rose, Latham, Ashurst - Law360
Alcon (ALC) Soars 6.0%: Is Further Upside Left in the Stock? - Yahoo Finance
Alcon Inc’s Acquisition of LENSAR Inc - Global Legal Chronicle
Related Content: Alcon to Acquire LENSAR | Business | Mar 2025 - Photonics Spectra
Alcon to buy Lensar in deal worth up to $430M - The Business Journals
Alcon to Acquire LENSAR - Photonics Spectra
Alcon to Acquire LENSAR | Business | Mar 2025 - Photonics Spectra
ALC Stock Rises Following the Merger Agreement With LENSAR - MSN
Alcon signs merger agreement to acquire Lensar - MSN
LENSAR INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of LENSAR, Inc.LNSR - Business Wire
Bernstein maintains Alcon Outperform rating, $110.50 target By Investing.com - Investing.com UK
Alcon lines up Lensar deal to expand laser cataract surgery options - Optics.org
BTIG Research Downgrades LENSAR to Neutral From Buy - MarketScreener
Alcon agrees to purchase LENSAR - Ophthalmology Times
Switzerland: Alcon agrees acquisition of Lensar for up to US$430m - Investors in Healthcare
LENSAR’s (LNSR) “Hold” Rating Reaffirmed at Lake Street Capital - Defense World
Alcon Agrees to Acquire Lensar, Inc. for Up to $430 Million - VisionMonday.com
BTIG cuts LENSAR stock rating post Alcon acquisition deal - Investing.com India
BTIG cuts LENSAR stock rating post Alcon acquisition deal By Investing.com - Investing.com Australia
$HAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of LENSAR, Inc.LNSR - The Malaysian Reserve
Latham & Watkins Represents LENSAR, Inc. in Acquisition by Alcon - Latham & Watkins LLP
Alcon to Acquire LENSAR in $430M Deal - USA Herald
Alcon to acquire Lensar for up to $430M - BioWorld MedTech
Norton Rose, Latham Steer Alcon's $430M Lensar Buy - Law360
Alcon agrees to acquire LENSAR for $14.00 per share - MSN
Lensar Inc Stock (LNSR) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.11%
0.79%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):